Patents by Inventor Thinnayam Naganathan Krishnamurthy

Thinnayam Naganathan Krishnamurthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
    Patent number: 10258616
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: April 16, 2019
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME
    Publication number: 20180064705
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 8, 2018
    Inventors: Helen Kathleen DANAGHER, Hassan MOHAMMAD, Malcolm WALDEN, Geoffrey Gerard HAYES, Jonathon Oliver WHITEHOUSE, Thinnayam Naganathan KRISHNAMURTHY, Ricardo Alberto VARGAS RINCON
  • Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
    Patent number: 9814710
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: November 14, 2017
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • Pharmaceutical compositions comprising hydromorphone and naloxone
    Patent number: 9700508
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: July 11, 2017
    Assignee: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME
    Publication number: 20160296516
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 13, 2016
    Inventors: Helen Kathleen DANAGHER, Hassan MOHAMMAD, Malcolm WALDEN, Geoffrey Gerard HAYES, Jonathon Oliver WHITEHOUSE, Thinnayam Naganathan KRISHNAMURTHY, Ricardo Alberto VARGAS RINCON
  • PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
    Publication number: 20130178492
    Abstract: The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.
    Type: Application
    Filed: May 10, 2011
    Publication date: July 11, 2013
    Applicant: Euro-Celtique S.A.
    Inventors: Helen Kathleen Danagher, Hassan Mohammad, Malcolm Walden, Geoffrey Gerard Hayes, Jonathon Oliver Whitehouse, Thinnayam Naganathan Krishnamurthy, Ricardo Alberto Vargas Rincon
  • ONCE-DAILY ORAL IR/CR PRAMIPEXOLE FORMULATION
    Publication number: 20120021057
    Abstract: An oral once-daily pramipexole formulation, comprising an immediate-release component and a controlled-release component, is provided wherein in preferred embodiments, both the immediate-release component and the controlled-release component comprise pramipexole The formulation is preferably in the form of a coated bead A method of manufacturing said formulation is also provided.
    Type: Application
    Filed: April 7, 2010
    Publication date: January 26, 2012
    Applicant: Purdue Pharma
    Inventor: Thinnayam Naganathan Krishnamurthy